Poor performance of laboratories assaying newly developed antiretroviral agents: Results for darunavir, etravirine, and raltegravir from the international quality control program for therapeutic drug monitoring of antiretroviral drugs in human plasma/serum
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
6Citaten
(Scopus)
Vingerafdruk
Duik in de onderzoeksthema's van 'Poor performance of laboratories assaying newly developed antiretroviral agents: Results for darunavir, etravirine, and raltegravir from the international quality control program for therapeutic drug monitoring of antiretroviral drugs in human plasma/serum'. Samen vormen ze een unieke vingerafdruk.